Bacterial and retroviral superantigens (SAGs) stimulate a high proportion of T cells expressing specific variable regions of the T cell receptor (TCR) ~ chain. Although most alleles and isotypes bind SAGs, polymorphisms of major histocompatibility complex (MHC) class II molecules affect their presentation to T cells. This observation has raised the possibility that a TCR-MHC class II interaction can occur during this recognition process. To address the importance of such interactions during SAG presentation, we have used a panel of murine T cell hybridomas that respond to the bacterial SAG Staphylococcal enterotoxin B (SEB) and to the retroviral SAG Mtv-7 when presented by antigen-presenting cells (APCs) expressing HLA-DK1. Amino acid substitutions of the putative TCR contact residues 59, 64, 66, 77, and 81 on the DK1/$ chain showed that these amino acids are critical for recognition of the SAG SEB by T ceils. TCK-MHC class II interactions are thus required for T cell recognition of SAG. Moreover, Mtv-7 SAG recognition by the same T cell hybridomas was not affected by these mutations, suggesting that the topology of the TCK-MHC class II-SAG trimolecular complex could be different from one TCR to another and from one SAG to another. S uperantigens (SAGs) 1 stimulate a high proportion of T cells bearing specific V~ regions of the TCR (reviewed in 1). This activation requires APCs expressing MHC class II molecules (2-4). The SAG family includes retroviral products of the mouse mammary tumor virus, and bacterial toxins produced mostly by Staphylococci and Streptococci (reviewed in 1). Unlike conventional antigens (Ags), SAGs bind outside of the polymorphic antigen binding groove of MHC class II molecules (5). Site-directed mutagenesis has shown that Staphylococcal enterotoxin A (SEA) interacts with histidine 81 of the MHC class II ~ chain (6, 7) while amino acids 36 and 39 of the DRot chain are critical for toxic shock syndrome toxin 1 (8) and SEB binding (9, and our unpublished observations).
S
uperantigens (SAGs) 1 stimulate a high proportion of T cells bearing specific V~ regions of the TCR (reviewed in 1). This activation requires APCs expressing MHC class II molecules (2) (3) (4) . The SAG family includes retroviral products of the mouse mammary tumor virus, and bacterial toxins produced mostly by Staphylococci and Streptococci (reviewed in 1). Unlike conventional antigens (Ags), SAGs bind outside of the polymorphic antigen binding groove of MHC class II molecules (5) . Site-directed mutagenesis has shown that Staphylococcal enterotoxin A (SEA) interacts with histidine 81 of the MHC class II ~ chain (6, 7) while amino acids 36 and 39 of the DRot chain are critical for toxic shock syndrome toxin 1 (8) and SEB binding (9, and our unpublished observations).
Experiments suggested at first the absence of TCR-MHC class II contact during SAG recognition. This conclusion was inferred from the fact that most class II molecules can present SAGs to a given T cell (4, (10) (11) (12) . Moreover, CD8 + T cells expressing TCKs restricted to MHC class I molecules recog-1 Abbreviations used in this paper: SAG, superantigen; SEA or B, Staphylococcal enterotoxin A or B.
nize the MHC class II-SAG complex (13) (14) (15) . Finally, the TCK can interact with SAGs in the absence of MHC class II positive cells although this interaction does not result in T cell activation (16, 17) . These results have led to the hypothesis that MHC class II molecules serve only as a scaffold for SAG presentation and are not directly in contact with the TCR. A more systematic analysis of SAG presentation suggests that TCK-MHC class II interactions are required for T cell stimulation by SAGs. Stimulation of T cell clones is affected by MHC class II polymorphisms (18) (19) (20) and a skewing of TCR-Ot chain expression among T cells reactive to retroviral and bacterial SAGs was reported (21) (22) (23) . Moreover, fine specificities of TCK for particular MHC class II-SAG complexes are influenced by the non-V/3 (D/3, J/3, Vot, and Jot) elements of the TCR suggesting that these regions might interact with MHC class II molecules (24, 25) . The crystal structure of the bacterial toxin SEB supports this hypothesis since the TCK and MHC class II binding regions are adjacent thus permitting a direct contact between the three molecules (26) .
To address a possible role for an interaction between TCR and MHC class II during SAG recognition, we have used mutant MHC class II molecules at putative TCK contact Generation of Mutant HLA-DR Molecules. The SmaI-BamHI cDNA fragment that encodes DR1 (DRBI*0101) 3 chains was cloned between the filled-in SalI site and the BamHI site of the eukaryotic expression vector RSV.3 (33, 34) . The cDNA fragment that encodes the DRc~ chain was also subcloned in the RSV.3 expression vector (35) . Site-specific mutagenesis of the DR3 chain cDNA was performed as previously described (7) using the PCR overlap extension technique (36) . The full-length PCR fragments carrying the mutations on the DR3 chain cDNA were digested with SacI and StuI. This 454-bp fragment was shuffled into the SacI-and StuI-digested wild-type DR1 cDNA cloned in the RSV.3 eukaryotic expression vector. Generation of the DRol mutant 39, 42, 46 has been described elsewhere (9) . All of the mutants generated by PCR were confirmed by nucleotide sequencing.
DNA Transfections. DNA transfections were performed using the calcium phosphate coprecipitation technique as previously described (7) . Homogeneous populations of DAP-3 cells expressing comparable levels of MHC class II molecules were obtained by two rounds of aseptic cell sorting on a FACStar | Plus (Becton Dickinson Immunocytometry Systems, San Jose, CA). Stable transfections of Mtv-7 sag gene in DAP-3 fibroblasts expressing wild-type or mutated MHC class II molecules were performed as previously described (9) .
Cytofluorometric Analysis of DAP-3 Cells
Transfected with HLA-DR Molecules. Cells were stained with either I.-243 or 50D6, a mouse anti-human MHC class II antibody that recognizes all DR alleles except DR7 and DRw53, followed by goat anti-mouse (GAM)-FITC (GIBCO BRL). As negative control, the different transfectants were stained with the secondary antibody alone. MHC class II expression was analyzed by flow cytometry using a FACScan | (Becton Dickinson Immunocytometry Systems).
Stimulation of Murine T Cell Hybridomas.
Stimulation of the different T cell hybridomas with recombinant SEB (rSEB; a generous gift ofJ. Kappler and P. Marrack, National Jewish Hospital, Denver, CO) was carried out as follows. 75 x 103 T cells/well were added to 2 x 104 DAP-3 fibroblasts expressing wild-type or mutated HLA-DR molecules. Different concentrations (0-1 #g/ml) of bacterial toxin SEB were added to the coculture in 96-well plates and incubated for 24 h at 37~ 5% CO2. Triplicates were performed for each experimental condition. T cell stimulation was determined by IL-2 production. IL-2 production was assayed by the capacity of the culture supernatants to support the proliferation of the IL2-dependent cell line CTLL.2, as measured using the hexosaminidase colorimetric assay (37) . Presentation of Mtv-7 SAG by mutated MHC class II molecules was performed as previously described (9) .
Toxin Binding Analysis. 20/zg of rSEB were iodinated using 0.5 #g of iodogen (Pierce Chemical Co., Rockford, IL) coated to tubes and 250 #Ci of l~SI (Amersham Corp., Toronto, Canada). Free iodine was removed from the labeled toxin using Sephadex G-10 exclusion chromatography. The ability of different HLA-DR mutants to bind SEB was determined as follows: 106 DAP-3 cells expressing the wild-type or mutated HLA-DR molecules were incubated with 100 ng of 12sI-toxins in 200/~1 of binding buffer (DMEM + 2% FCS + 0.1% NAN3) for 4 h at 37~ Tubes were agitated every 15-20 min. Duplicates were performed for each condition. After incubation, the cells were pelleted through an oil cushion (84% silicone oil and 16% mineral oil); pellets were cut from the tube and were then counted on a gamma-counter. Nonspecific binding was determined in the presence of a 100-fold excess (10 #g) of cold toxin.
Results

Mutations of Putative TCR Contact Residues on HLA-DRlfl Chain Affect rSEB Presentation to V~8.1 Murine T Cell Hybridomas.
To test the importance of TCR.-MHC class II interactions for the recognition of SAG by T cells, we have substituted several of the putative TCR contact residues on the /3 chain of HLA-DR1 by alanines (Table 1 ). These mutated class II molecules were then used to stimulate two SEBresponsive VB8.1 § T cell hybridomas (Fig. 1) . Stimulation of 3DT52.5.8 by rSEB was observed with all the APCs expressing the different mutated MHC class II molecules. Transfected cells expressing the wild-type DR1 molecule stimulated IL-2 production by both V38.1 + T cell hybridomas even at concentrations of SEB as low as 1 ng/ml, whereas untransfected fibroblasts did not present SEB. Efficient presentation of rSEB by the MHC class II molecules mutated along the c~-helix of the fll domain (DR1 59.64, DR1 66.68, DR1 77.78, DR.1 81A, and DR1 81Y) was observed with differences in the dose-response curve for each mutant (Fig.  1) . Most of the mutations involving these residues led to an effect on the dose-response curve for both V38.1 hybridomas tested, namely 3DT52.5.8 ( present the toxin to both hybridomas even at the highest concentration tested ( Fig. 1 ). These results thus indicate that the putative TCR contact residues/359,/364,/366, B77, and/381 are involved in the presentation ofrSEB to the V/38.1 T cells, 3DT52.5.8 and KR3.
Mutations of Putative TCR Contact Residues on HLA-DRfl l Chain Abolish Presentation of SEB to Vfl6 Murine T Cell Hybridomas.
The effect of these mutations was then assessed on the presentation of rSEB to V/36 + hybridomas, Kmls 13.11, Kmls 12.6, and RG 17. The latter will respond to rSEB only when presented by human MHC class II molecules (18) . As also shown in Fig. 2 A, they require 10-fold higher levels of rSEB to produce detectable levels of IL-2 when compared with V/~8.1 hybridomas (Fig. 1) . A significant decrease of the T cell response to SEB was observed when class II molecules mutated at TCR residues 59 and 64 were used to present rSEB to Kmls 13.11 ( Fig. 2 A) ; IL-2 production required a 10ofold higher concentration of SEB when compared with II molecules. T cell hybridomas were incubated 24 h at 37~ with DAP-3 cells expressing wild-type or mutated MHC class II molecules in the presence of 0-100/zg/ml of toxins. Each condition was done in triplicate. Stimulation of the T cell hybridomas is indicated by ILo2 production and was determined by the ability of culture supernatants to support the proliferation of the IL-2-dependent cell line CTLL.2.
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Labrecque et al. wild-type class II molecules. In contrast cells expressing mutants DR1 66.68 were as efficient in presenting rSEB as ceils expressing the wild-type DR1 molecule. Moreover, as shown in Fig. 2 B, mutation of residue B81 to either an alanine (DR1 81A) or a tyrosine (DR1 81Y) complete abrogated presentation of rSEB to Kmls 13.11 even though they express high and comparable levels of MHC class II molecules ( Table 1) . Mutation of the other putative TCR contact residues/~77 (DK1 77.78) (Fig. 2 B ) had no effect on rSEB presentation to Kmls 13.11. These results indicate that TCtk residues/~59, /364, and ~81 are critical for SEB recognition by Kmls 13.11 T cells in the context of DR1.
The effect of the same mutations was also determined for two other VB6 + murine T cell hybridomas. Interestingly, presentation of rSEB to Kmls 12.6 involved different putative TCR contact residues on MHC class II molecules than what was observed with Kmls 13.11. As illustrated in Fig.  2 C mutants B59.64 and ~66.68 had a moderate effect on SEB presentation in quantitative dose response curve assays. Similar results were obtained for mutants 77.78 (Fig. 2 D) . However mutation of residue ~81 to an alanine but not to a tyrosine abolished rSEB presentation to Kmls 12.6 (Fig.  2 D) . These results demonstrate the critical role of residue 81 in the presentation of SEB to this TCR. They also suggest a role for aUelic polymorphism in the presentation of bacterial toxins to different TCRs since distinct amino acids at position 81 lead to different outcome, A distinct pattern was observed with the other V36 + T cell hybridoma R,G 17. Mutations at positions 59.64 and 66.68 lead to drastic reduction of the capacity of these class II molecules to present SEB (Fig. 2 E) . Moreover the alanine substitution at position 381 of DR1 affected the stimulation of RG 17 ( Fig. 2/7 ). It is also interesting to note a significant enhancement in the stimulation of RG 17 by mutant DR1 77.78. It is possible that presence of small side chains at these positions facilitates the interaction of the DR.1-SEB complex with the TCR. This effect was not observed with the other hybridomas. These results suggest that TCR-MHC class II interactions are required for efficient stimulation of T cells with rSEB. Moreover, the topology of the interaction between the TCR and MHC class II molecules is different from one TCK to another since distinct TCR, residues affect the response of each hybridoma.
Mutation of Putative TCR Contact Residues on HLA-DRlfl
Chain Does Not Affect SEB Binding.
Quantitative binding assays were performed to verify if mutations of putative TCR contact residues on the ~ chain of DR1 affected the interaction with SEB. Fig. 3 shows that all the mutants efficiently bound rSEB. The variation in the amount of 12SI-rSEB binding was always correlated with the level of MHC class II expression on the different transfectants (Fig. 3) . Specificity of the binding is shown using DAP-3 untransfected cells which do not bind 12SI-rSEB, Moreover, mutant DRa39.42.46 fails to bind lz~I-rSEB in this assay and had previously been shown to lose the capacity to present SEB to T cells (9) .
Mutation of residue ~81 (either to an alanine or a tyrosine) on HLA-DR. [~Z rSEB I L-243 [Z~ 50D6 Binding is expressed as bound cpm. The different transfectants were also stained with 1:243 and 50D6 mAbs to determine levels of MHC class II expression by flow cytometry. M.F.V., mean fluorescence value. SEB binding is not affected by these mutations. DILl 81A or DILl 81Y bind rSEB proportionally to the levels of class II molecules expression at the cell surface (Fig. 3) . Moreover, the binding of toxic shock syndrome type I is not impaired suggesting that these mutations do not alter the conformation of HLA-DR1 (not shown). As expected, binding of SEA is completely abolished by mutation of residue 381 (not shown) thus confirming our and others results (6, 7).
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Mtv-7 SAG Presentation to Different Murine T Cell Hybridomas by HLA-DRI Mutated at the Putative TCR Contact ResidueflS1.
The requirement for TCR-MHC class II interactions in bacterial SAG recognition raised the possibility that it could also play a role in presentation of endogenous retroviral SAG such as Mtv-7. Mutation of residue fl81 of HLA-DR1 to an alanine affects the rSEB response of the Vfl6 + hybridomas to rSEB. To test a possible effect of this mutation on Mtv-7 SAG presentation, DILl and DR1 81A were transfected with the Mtv-7 Sag gene and used to stimulate the routine T cell hybridomas that e~ciently respond to Mtv-7 SAG. As shown in Fig. 4 , the two Vfl6 + hybridomas (Kmls 13.11 and Kmls 12.6) responded as ef~ciently as the Vfl8.1 + hybridoma KR3 to Mtv-7 SAG presented by wild-type DR1 or DR1 81A. Similar results were previously reported with another VB8 + hybridoma stimulated with DILl 81A cells transfected transiently with Mtv-7 Sag (9). This result is in sharp contrast to SEB presentation where Vfl8 + hybridomas responded well while Vfl6 + cells were not stimulated using class II molecules DR1 81A (Figs. 1 and 2 ). These resuhs suggest that stimulation of T cells with retroviral or bacterial SAGs requires different TCIL-MHC class II interactions. Figure 5 . Position of the residues that have been substituted on DRlfl chain. The DRo~ chain is drawn in black and the DKfl chain in white. The MHC class II molecule drawing is adapted from the crystallographic structure of HLA-DR1 described by Brown et al. (41) . Mutated residues are indicated by circles. Small dots (.) represent residues that do not affect rSEB presentation. Solid circles (0) represent residues that lead to a total abrogation ofrSEB presentation; ~tckedcircles (@) represent residues that practically affect presentation of rSEB; and empty circles (O) represent residues that enhance rSEB presentation. A model for ternary complex formation between DR1, SEB, and TCR based on the DRI:SEB crystal structure analysis and DR1/3 chain mutation that affect T cell stimulation but not SEB, Dlklc~l/31 domains and peptide are shown in blue. SEB is shown in red and DR1 residues that affect T cell stimulation but not SEB binding are shown in yellow. A model of the Vot and V~ regions of the TCR, based on known immunoglobulin structures, is shown in white. The TCR model is positioned based on mutational data for both S. aureus toxins and TCRs as described (40) . The model is consistent with the occurrence of direct interactions between DRI~ chain residues and TCR residues in SAG-mediated stimuiation of T cells.
Discussion
In this study, we have clearly demonstrated that residues that are not involved in the binding of bacterial SAGs are important for the stimulation of T lymphocytes by these molecules. Different murine T cell hybridomas that respond efficiently to rSEB and Mtv-7 SAG when presented by HLA-DR1 were used. Our results indicate that histidine 81 is critical for the formation of the trimolecular complex involving the T C R of the different VB6 + routine T cell hybridomas since substitution of histidine/381 of DR1 to either a tyrosine or an alanine completely abrogated or strongly reduced SEB presentation to these T cells. This effect is not due to a decreased binding of this toxin on the mutated M H C class II molecules (Fig. 3) . The lack of serological differences be-tween mutated and wild-type DR molecules using a panel of 13 DR-specific mAbs indicates that these mutations did not lead to gross conformational modifications (data not shown). The latter is supported by the fact that DR1 molecules having the mutation 381Y are still able to present antigenic peptides to six of eight DRl-restricted T cell lines (6) and SAGs to the V38.1 hybridomas used in the present study. Interestingly, substitution of residue 381 of HLA-DR1 to a tyrosine does not abolish the SEB response of Kmls 12.6 and RG 17 although alanine substitution strongly affected this response. It is possible that substitution of the histidine 381 to an alanine, which has a very small side chain, does not allow an interaction with this particular TCR but that substitution to a tyrosine, which also possesses an aromatic side chain, permits a more efficient contact. Although the crystal structure of class II suggests that H81 might interact with peptide (38) , our results clearly show that residue 381 is involved in an interaction with the TCR (Fig. 5) . Indeed a recent report has demonstrated a critical role for this residue in presentation but not binding of class II-restricted peptides (39) . It is however possible that unconventional interactions between TCR and MHC occur during presentation of bacterial toxins since SEB binds on the class II o~ chain and thus obscures TCR contact residues on this side of the groove (40) . With the knowledge that residue 381 is directly involved in the binding of SEA (6, 7) , it is more than likely that in SEA recognition the TCR will interact with other residues on MHC class II molecules.
The role of TCR-MHC class II interactions in the response to SAG was further confirmed by the differential effect of 366 on T cell hybridomas. Mutation of this residue almost abolished the presentation ofrSEB to RG 17 and Kmls 13.11 but had little effect on other T cells. Although this mutation was done in conjunction with the mutation of residue 368, which is pointing into the antigen binding groove, we do believe that the effect observed is due to mutation of the putative TCR contact residue 366 (Fig. 6) . Mutations of the putative TCR contact residues 359 and 364 affect the presentation of rSEB to four out of five hybridomas used in these experiments. These results suggest that different routine T cell hybridomas see the SAG-MHC class II complex in distinct ways (Fig. 5) . Moreover, our results indicate that a particular TCR does not interact with all putative TCR contact residues located on the MHC class II molecules. In contrast to the negative effect of mutation 59, 64, 66, and 81A and 81Y, substitution of 3T77A, Y78A led to a significant enhancement of RG17 response to SEB. This effect is more likely to be due to the mutation of residue 77 which is pointing out toward the TCR whereas the aromatic ring and lateral side chain of residue 378 is oriented toward the peptide binding groove (Fig. 6) .
Recently, Ehrich et al. (39) have reported that mutation of putative TCR contact residues on the a and 3 chain of I-E k affect SEA presentation to T cells. Interestingly, not all murine T cell hybridomas were affected by mutation of a particular TCR contact residue confirming our results. Moreover, they showed that the same T cell hybridoma interact with different TCR contact residues in Ag-and SAGspecific responses (39) . Our results also showed that the same T cell hybridoma interact with different TCR contact residues for SEB and Mtv-7 SAG recognition. This different topology of interaction could result from the use of different SAG binding sites on MHC class II molecules (9) . The localization of the SAG on the MHC molecule will probably determine the orientation of the CDR4 loop and by the same way the overall topology of the TCR-class II.
The results presented here favor a model in which TCR-MHC class II-SAG interactions occur. The fact that SAG presentation is not truly MHC restricted does not rule out a TCR-MHC class II interaction, since the putative TCR contact residues on MHC class II molecules are highly conserved throughout evolution (41, 42) . 8 of 10 putative TCR contact residues of the class II/3 chain are conserved between wild mice, laboratory mice, and humans. Interestingly, the presence of an histidine at position 381 is conserved among all human and murine MHC class II alleles and isotypes with the exception of DRw53 and I-A ~. Other TCR contact residues are also identical within a class II isotype as all HLA-DR alleles share the same TCR contact residues. Moreover, some of these amino acids (5 out of 24) are conserved between MHC class I and class II molecules, which could explain the recognition by CD8 + T cells of SAG-MHC class II complexes. Consistent with this view, CD4 § and CD8 § T cells use the same pool of V regions to recognize MHC and Ags (43) (44) (45) (46) further supporting the possibility that TCRs expressed by CD8 + T cells can interact with MHC class II molecules.
The importance of TCR-MHC class II interactions will probably be influenced by the affinity of the TCR for the SAG. Weak SAGs or TCRs with low af~nity for SAGs will probably show a pattern of MHC restriction that will be influenced by putative TCR contact residue of the MHC class II molecule. Thus, it is interesting to note that the V38.1 hybridomas, which are less dramatically affected by the MHC mutation, respond to much lower concentration (10-30-fold) of SEB and are likely to have a higher affinity for the toxin than the V36 § T cells. The existence of a direct contact between the TCR and MHC class II molecules in SAG recognition may have important implications during the in vivo response to SAG. Bacterial and retroviral SAGs have been associated with the pathogenesis of several diseases (1, (47) (48) (49) (50) (51) (52) (53) (54) . MHC dass II polymorphisms of TCR contact residues may have an important role to play in the susceptibility to SAGrelated diseases and on the level of T cell expansion, deletion, and unresponsiveness observed after SAG encounter.
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